Yuntao J. Liu

Tianjin, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Treatment practice and outcomes in 125 patients with autoimmune hemolytic anemia: a single-center retrospective analysis

Treatment practice and outcomes in 125 patients with autoimmune hemolytic anemia: a single-center retrospective analysis

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: April 16, 2026

Natural variation in the COT1 promoter improves rice seedling cold tolerance by OsCBF3-dependent transcriptional activation.

Natural variation in the COT1 promoter improves rice seedling cold tolerance by OsCBF3-dependent transcriptional activation.

Journal: Plant communications

Published: March 17, 2026

Venetoclax Plus Pediatric Regimen in Adolescents and Adults with Ph-Negative Acute Lymphoblastic Leukemia.

Venetoclax Plus Pediatric Regimen in Adolescents and Adults with Ph-Negative Acute Lymphoblastic Leukemia.

Journal: Blood

Published: February 04, 2026

Gene- and subtype-dependent prognostic impact of ras pathway mutations in acute myeloid leukemia: a cohort study of 2,500 patients.

Gene- and subtype-dependent prognostic impact of ras pathway mutations in acute myeloid leukemia: a cohort study of 2,500 patients.

Journal: Blood cancer journal

Published: February 02, 2026

Durable deep molecular response via CD19 chimeric antigen receptor T-cell therapy combined with a third-generation tyrosine kinase inhibitor in acute leukemia of ambiguous lineage with the Philadelphia chromosome: a potential strategy for transplant-ineligible patients.

Durable deep molecular response via CD19 chimeric antigen receptor T-cell therapy combined with a third-generation tyrosine kinase inhibitor in acute leukemia of ambiguous lineage with the Philadelphia chromosome: a potential strategy for transplant-ineligible patients.

Journal: Haematologica

Published: January 13, 2026

Impact of Fusion Partners and Transplantation Benefit in Intensively Treated KMT2A-Rearranged Acute Myeloid Leukemia.

Impact of Fusion Partners and Transplantation Benefit in Intensively Treated KMT2A-Rearranged Acute Myeloid Leukemia.

Journal: Cancers

Published: January 08, 2026

Single-cell dissection of plasma cell clonal evolution to smoldering multiple myeloma after CD19 CAR-T cell therapy in B-cell acute lymphoblastic leukemia.

Single-cell dissection of plasma cell clonal evolution to smoldering multiple myeloma after CD19 CAR-T cell therapy in B-cell acute lymphoblastic leukemia.

Journal: Haematologica

Published: November 19, 2025

Daunorubicin-45 Vs. Daunorubicin-60 for Induction in Intermediate-Age Patients of AML: Results From a Randomized Trial.

Daunorubicin-45 Vs. Daunorubicin-60 for Induction in Intermediate-Age Patients of AML: Results From a Randomized Trial.

Journal: Cancer science

Published: October 26, 2025

The prognostic role of myeloid-related gene mutations in adult acute lymphoblastic leukemia.

The prognostic role of myeloid-related gene mutations in adult acute lymphoblastic leukemia.

Journal: Haematologica

Published: October 13, 2025

Correction: Olverembatinib combined with venetoclax and reduced-intensity chemotherapy for adult newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a single-center, single-arm, phase 2 trial.

Correction: Olverembatinib combined with venetoclax and reduced-intensity chemotherapy for adult newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a single-center, single-arm, phase 2 trial.

Journal: Leukemia

Published: September 05, 2025

Progression significance for low-level aberrant B-lymphoblasts in chronic myeloid leukaemia patients.

Progression significance for low-level aberrant B-lymphoblasts in chronic myeloid leukaemia patients.

Journal: Clinical and translational medicine

Published: August 13, 2025

Efficacy and safety of mini-cvd combined with venetoclax and azacitidine in philadelphia chromosome-negative acute leukemia of ambiguous lineage: a single-center retrospective study.

Efficacy and safety of mini-cvd combined with venetoclax and azacitidine in philadelphia chromosome-negative acute leukemia of ambiguous lineage: a single-center retrospective study.

Journal: Annals of hematology

Published: July 29, 2025

Showing 1-12 of 47

Last Updated: 09/26/2026